What are the therapeutic uses of niacin (vitamin B3)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Therapeutic Uses of Niacin (Vitamin B3)

Niacin is currently NOT recommended for routine cardiovascular risk reduction, but retains FDA-approved indications for specific dyslipidemia scenarios when used as monotherapy, particularly in patients with severe hypertriglyceridemia at risk for pancreatitis who cannot tolerate or have failed other therapies. 1

Current Evidence-Based Recommendations

Strong Recommendation AGAINST Routine Use

The most recent 2025 AACE guidelines provide a strong recommendation against using niacin in adults with hypertriglyceridemia (150-499 mg/dL) who have atherosclerotic cardiovascular disease (ASCVD) or are at increased risk. 1 This represents a significant shift from historical practice.

Key Evidence:

  • Only trivial reduction in myocardial infarction (6 fewer per 1000 individuals, with confidence intervals crossing no effect)
  • Large increase in adverse events (98 more discontinuations per 1000 individuals)
  • No mortality benefit demonstrated
  • The 2016 FDA explicitly recommended against routine use or combination with statins after the AIM-HIGH trial showed no cardiovascular benefit when added to statin therapy 2

Remaining FDA-Approved Indications

Despite the strong recommendation against routine use, niacin retains specific FDA-approved indications 2:

Lipid Modification (as adjunct to diet):

  • Reduce elevated total cholesterol, LDL-C, apolipoprotein B, and triglycerides
  • Increase HDL-C in primary hyperlipidemia and mixed dyslipidemia
  • In combination with bile acid binding resins for primary hyperlipidemia

Secondary Prevention:

  • Reduce risk of recurrent nonfatal MI in patients with history of MI and hyperlipidemia
  • Slow progression or promote regression of atherosclerotic disease in CAD patients (when combined with bile acid binding resin)

Severe Hypertriglyceridemia:

  • Adjunctive therapy for adults with severe hypertriglyceridemia at risk of pancreatitis who fail dietary interventions 2

Critical Clinical Considerations

When Niacin Might Still Be Considered

Shared decision-making is essential when considering niacin for 1:

  • Severe hypertriglyceridemia (though no evidence supports pancreatitis prevention)
  • Patients unable to tolerate statins
  • Statin-naïve patients (though other options are preferred)

Absolute Contraindications 3, 2

Do NOT use niacin if:

  • Active liver disease or hepatic transaminases >2-3 times upper limit of normal
  • Active peptic ulcers or arterial bleeding
  • Persistent severe cutaneous symptoms
  • Persistent hyperglycemia or new-onset diabetes complications
  • Acute gout
  • Unexplained abdominal pain or GI symptoms
  • New-onset atrial fibrillation or unexplained weight loss

Dosing and Monitoring Requirements

Initial dosing: 2

  • Start at 500 mg at bedtime with low-fat snack
  • Titrate slowly: increase by 500 mg every 4 weeks maximum
  • Maintenance: 1000-2000 mg daily (doses >2000 mg not recommended)
  • Women may respond at lower doses than men

Required monitoring: 3

  • Before initiation: hepatic transaminases, fasting glucose or HbA1c, uric acid
  • During up-titration and every 6 months: repeat above labs
  • With fibrate combination: renal function (creatinine, eGFR) at baseline, 3 months, then every 6 months

Significant Adverse Effects Profile

Common and serious adverse effects include: 1

  • Flushing and pruritus (most common)
  • Gastrointestinal distress
  • Hepatotoxicity (elevated liver enzymes)
  • Hyperglycemia and increased diabetes incidence
  • Gouty arthritis
  • Myalgias and musculoskeletal symptoms
  • Increased infection and bleeding risk
  • New-onset atrial fibrillation

Strategies to minimize flushing: 3

  • Take with food
  • Premedicate with aspirin 325 mg 30 minutes before dosing
  • Slow titration over weeks
  • Avoid alcohol, hot drinks, and spicy foods around dosing time

Critical Drug Interactions

Never combine with gemfibrozil due to increased rhabdomyolysis risk 3

Not recommended with statins based on lack of additional cardiovascular benefit and increased adverse events 1, 2

Other Biological Functions (Non-Cardiovascular)

Beyond cardiovascular indications, niacin serves as:

  • Essential cofactor for NAD/NADP coenzymes in cellular energy production 4
  • Potential neuroprotective agent in neurodegenerative diseases (investigational) 4
  • Possible antiviral properties through GPR109A receptor activation (emerging research) 5
  • Treatment for pellagra (niacin deficiency)

Note: Nicotinamide (niacinamide) differs from nicotinic acid and is used for dermatologic conditions (actinic keratosis, skin cancers) without the cardiovascular effects or flushing 6

Bottom Line Algorithm

  1. Do NOT use niacin for routine cardiovascular risk reduction in patients on statins
  2. Consider only with extensive shared decision-making for severe hypertriglyceridemia at pancreatitis risk when other therapies have failed
  3. If prescribing: ensure no contraindications, start low (500 mg), titrate slowly, monitor closely for adverse effects
  4. Discontinue immediately if hepatotoxicity, persistent hyperglycemia, gout, atrial fibrillation, or intolerable side effects occur

References

1
Guideline

american association of clinical endocrinology clinical practice guideline on pharmacologic management of adults with dyslipidemia.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2025

Related Questions

What does NE (niacin equivalents) mean in vitamin B3?
What is the maximum safe daily intake of vitamin B3 (niacin) from diet and supplements combined?
What are the recommended pediatric dosing guidelines for niacin (nicotinic acid or nicotinamide) in infants, children, and adolescents?
What oral or intravenous niacin (vitamin B3) supplementation dose should a generally healthy adult without niacin deficiency aim for?
What is the ideal oral dose of niacinamide (nicotinamide) for a generally healthy adult?
In a man in his 40s with a 2‑day history of uncomfortable, raised erythematous papules on the glans (corona) and distal third of the penile shaft, without vesicles or ulcers, what is the appropriate treatment?
In a newborn with congenital diaphragmatic hernia, how should surgical repair be performed, including timing after stabilization, preferred approach, and techniques for closing the diaphragmatic defect?
When should a radial artery forearm flap be used, including its indications, contraindications, and postoperative management?
For a patient experiencing hypotension due to acebutolol, should the acebutolol dose be reduced to 100 mg daily?
What is the emergency workup and management for a reproductive‑age woman presenting with severe abdominal pain and vaginal clots?
In a patient with disc herniation, what is the most appropriate steroid to use for symptom improvement?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.